BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jabbal S, Anderson W, Short P, Morrison A, Manoharan A, Lipworth BJ. Cardiopulmonary interactions with beta-blockers and inhaled therapy in COPD. QJM 2017;110:785-92. [PMID: 29025008 DOI: 10.1093/qjmed/hcx155] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
Number Citing Articles
1 Sykes DA, Jiménez-Rosés M, Reilly J, Fairhurst RA, Charlton SJ, Veprintsev DB. Exploring the kinetic selectivity of drugs targeting the β1 -adrenoceptor. Pharmacol Res Perspect 2022;10:e00978. [PMID: 35762357 DOI: 10.1002/prp2.978] [Reference Citation Analysis]
2 Chapman KR, Wise RA, Scirica BM, Bhatt DL, Daoud SZ, Lythgoe D, Gil EG. Long-acting antimuscarinic therapy in patients with chronic obstructive pulmonary disease receiving beta-blockers. Respir Res 2021;22:272. [PMID: 34686204 DOI: 10.1186/s12931-021-01861-2] [Reference Citation Analysis]
3 Akbar Z, Rehman S, Khan A, Khan A, Atif M, Ahmad N. Potential drug-drug interactions in patients with cardiovascular diseases: findings from a prospective observational study. J Pharm Policy Pract 2021;14:63. [PMID: 34311787 DOI: 10.1186/s40545-021-00348-1] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
4 Gulea C, Zakeri R, Alderman V, Morgan A, Ross J, Quint JK. Beta-blocker therapy in patients with COPD: a systematic literature review and meta-analysis with multiple treatment comparison. Respir Res 2021;22:64. [PMID: 33622362 DOI: 10.1186/s12931-021-01661-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
5 Su VY, Yang YH, Perng DW, Tsai YH, Chou KT, Su KC, Su WJ, Chen PC, Yang KY. Real-world effectiveness of medications on survival in patients with COPD-heart failure overlap. Aging (Albany NY) 2019;11:3650-67. [PMID: 31175265 DOI: 10.18632/aging.102004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
6 Jabbal S, Lipworth BJ. Sensitivity of Lung Resistance and Compliance to Beta-Blocker Induced Bronchoconstriction and Long Acting Beta-Agonist Withdrawal in COPD. Lung 2018;196:15-8. [PMID: 29264651 DOI: 10.1007/s00408-017-0079-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
7 Jabbal S, Lipworth BJ. Tolerability of Bisoprolol on Domiciliary Spirometry in COPD. Lung 2018;196:11-4. [PMID: 29030687 DOI: 10.1007/s00408-017-0061-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]